Gamelin Erick sold ACRV
May 14, 2026 · Form 4 insider transaction
Gamelin Erick sold 404 shares of Acrivon Therapeutics, Inc. at $1.92 per share, a transaction worth $775.68. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
404
Price
$1.92
Total value
$775.68
InsiderGamelin Erick
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMay 14, 2026
Filing dateMay 18, 2026
Shares owned after14,408
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.